Evidence map›Paper›PMID 38156226›Full record

ReviewAntimicrobial stewardship & healthcare epidemiology : ASHE2023

Antifungal stewardship: the Latin American experience.

Fernando Riera, Jorge Cortes Luna, Ricardo Rabagliatti, Pablo Scapellato, Juan Pablo Caeiro, Marcello Mihalenko Chaves Magri, Claudia Elena Sotomayor, Diego Rodrigues Falci

Open access · goldAbstract readReview
In one paragraph

Review in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Changing Climate, ChangingJournal of fungi (Basel, Switzerland) · 2025
    Review
  7. Review
  8. Article
  9. Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 4 countries.

Fernando RieraDivision of Infectious Diseases, Sanatorio Allende Córdoba, Córdoba, Argentina.ORCID https://orcid.org/0000-0002-0618-1899
Jorge Cortes LunaMedicine Department of Internal Medicine School of Medicine, Universidad Nacional de Colombia, Colombia.ORCID https://orcid.org/0000-0002-0882-9652
Ricardo RabagliattiDepartamento de Enfermedades Infecciosas del Adulto, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Pablo ScapellatoChief Infectious Diseases Unit, Hospital D.F. Santojanni, Medicina Universidad Favaloro, Argentina.ORCID https://orcid.org/0000-0001-5072-6318
Juan Pablo CaeiroHIV/Infectious Diseases Services at AltaMed, Infectious Diseases, Universidad Nacional de Córdoba, Córdoba, Argentina.
Marcello Mihalenko Chaves MagriInfectious Diseases Services, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0001-7996-8265
Claudia Elena SotomayorCIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Laboratory of Innate Immunity to Fungal Pathogens, Córdoba, Argentina.ORCID https://orcid.org/0000-0003-2449-0852
Diego Rodrigues FalciInfectious Diseases Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Universidad Nacional de Córdoba · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARFavaloro University · ARHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital de Clínicas de Porto Alegre · BRPontificia Universidad Católica de Chile · CLUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antifungal stewardship is a critical component of healthcare management that focuses on optimizing the use of antifungal medications to improve patient outcomes, minimize resistance, and reduce healthcare costs.  In resource-limited settings, the prevalence of fungal infections remains a significant health concern, often exacerbated by factors such as compromised immune systems, inadequate diagnostic capabilities, and limited access to antifungal agents. This paper reviews the current state of antifungal stewardship practices in developing countries, addressing the unique socioeconomic and healthcare landscape.

Identifiers

PMID38156226
PMCPMC10753509
OpenAlexW4389351453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.